TGA regulatory consultants in Sydney Australia

TGA Regulatory Consulting — Sydney, Australia

TGA Regulatory Consultant

Specialist TGA regulatory consultants based in Sydney. ARTG registration, Australian sponsor services, TGA GMP compliance and audit readiness — for pharmaceutical and medical device companies entering or operating in the Australian market.

Sydney, AU

TGA consultant base

TGA · FDA · EMA

Regulatory agencies navigated

A1 Rating

TGA GMP compliance achieved

19+ years

Pharmaceutical industry experience

Why TPC for TGA work

TGA regulatory consultants in Sydney — with US reach

Trans-Pacific Compliance provides specialist TGA regulatory consulting for pharmaceutical and medical device companies seeking to register products in Australia. Our consultants are based in Sydney, with direct experience across all major TGA registration pathways — prescription medicines, OTC, complementary medicines and medical devices.

Our team has achieved an A1 TGA GMP compliance rating — the highest rating awarded by the TGA under the Therapeutic Goods Act — and has navigated routine TGA and FDA audits successfully. We understand what the TGA looks for, and we prepare our clients accordingly.

Because we also hold deep FDA expertise, Australian companies seeking US approval and US companies entering Australia work with one consistent team across both markets — not two separate firms with separate strategies.

Sydney, NSW, Australia · US presence
Talk to a TGA consultant
TGA ARTG regulatory dossier preparation

Key requirement for overseas companies

All products sold in Australia must have an Australian sponsor on the ARTG

The TGA requires an Australian sponsor — a person or business residing or incorporated in Australia — to take legal responsibility for every product on the ARTG. This is not a formality: the sponsor manages post-market obligations, TGA correspondence, adverse event reporting and ongoing ARTG maintenance. Trans-Pacific Compliance provides Australian sponsor services for overseas companies, acting as your local TGA point of contact throughout the product's registered life.

TGA Services

End-to-end TGA regulatory support

From pathway strategy through ARTG registration, GMP compliance and ongoing sponsor obligations — we cover every stage of the TGA regulatory lifecycle.

TGA Regulatory Strategy & Pathway Planning

Entering the Australian market requires choosing the right TGA registration pathway for your product category, risk classification and existing overseas approvals. We define that pathway early — saving time, cost and the risk of a misdirected submission.

  • Product category and registration pathway determination
  • Prescription, OTC, complementary and device routes
  • Leveraging overseas approvals (FDA, EMA) for TGA registration
  • Target evidence profile and dossier gap analysis
  • Multi-jurisdictional strategy (TGA + FDA/EMA)
Learn more

Australian Sponsor Services

Products supplied in Australia must be on the ARTG under an Australian sponsor — a local entity that takes legal responsibility for the product. We act as your Australian sponsor, managing the full TGA relationship from submission through to ongoing post-market obligations.

  • Australian sponsor designation and contractual arrangement
  • Sponsor obligations management (ongoing)
  • Post-market adverse event and defect reporting
  • TGA correspondence and query management
  • ARTG entry maintenance and variation management
Learn more

ARTG Registration & TGA Dossier Preparation

A TGA dossier must meet strict evidence and formatting requirements. We prepare and validate dossiers for prescription medicines, OTC products, complementary medicines and medical devices — managing the full lifecycle from initial lodgement through evaluation.

  • Full CTD/eCTD dossier preparation and validation
  • Prescription, OTC and complementary medicine applications
  • Pre-submission planning and TGA pre-application consultation
  • TGA evaluation question responses
  • ARTG variation (administrative and technical) management
Learn more

TGA Medical Device Registration

Medical devices sold in Australia must be included on the ARTG under the TGA's device classification framework. We support device sponsors through classification, conformity assessment, ARTG registration and ongoing post-market compliance.

  • Device classification (Class I, IIa, IIb, III, AIMD)
  • Conformity assessment and evidence preparation
  • ARTG inclusion for medical devices and IVDs
  • Essential Principles compliance documentation
  • Post-market surveillance and mandatory reporting
Learn more

TGA GMP Compliance & Audit Readiness

TGA GMP compliance is a continuous requirement for manufacturers and sponsors. We help pharmaceutical manufacturers prepare for TGA GMP inspections, respond to audit findings, and maintain the A1 compliance standard that protects your ARTG entries.

  • Pre-inspection TGA GMP documentation audit
  • Mock TGA inspections
  • SOP review and gap remediation
  • GMP audit response and CAPA development
  • Ongoing GMP compliance monitoring
Learn more

TGA Liaison & Regulatory Intelligence

Direct, effective communication with the TGA requires knowledge of how the agency operates and what it expects. We manage TGA correspondence, facilitate pre-application consultations, respond to evaluation questions, and keep you informed of regulatory changes relevant to your products.

  • TGA correspondence and formal liaison management
  • Pre-application and pre-submission consultation
  • Evaluation question and objection responses
  • TGA guidance monitoring and change impact assessment
  • Post-market reporting and regulatory obligation tracking
Learn more

How we work

From first call to ARTG registration

01

Free consultation

We discuss your product, its category and your Australian market goals. No obligation — this call is about understanding your situation.

02

Pathway assessment

We identify the right TGA registration route, review your existing data against TGA evidence requirements, and map any gaps.

03

Sponsor arrangement

If you need an Australian sponsor, we put the contractual and operational arrangements in place before lodgement.

04

Dossier preparation

Our consultants prepare and validate the full submission dossier — CTD/eCTD format — to TGA standards, covering CMC, clinical and nonclinical modules.

05

Evaluation and ARTG

We manage the TGA evaluation — responding to evaluation questions, tracking the application, and securing ARTG inclusion.

Your TGA team

Sydney-based TGA consultants — not offshore coordinators

Every TGA engagement is led by Rani Sabhavat or Leah Thompson — senior consultants based in Sydney with hands-on experience across TGA submissions, GMP audits, ARTG registration and ongoing sponsor obligations. Leah Thompson has held an executive position on the APIMAA board and has directly liaised with the TGA on GMP regulation implementation.

  • TGA ARTG registration — all categories
  • Australian sponsor services
  • A1 TGA GMP compliance rating achieved
  • APIMAA Executive Board member
  • Cross Functional AP — TGA Licence
  • TGA & FDA audit management
Meet the team
Trans-Pacific Compliance TGA regulatory consulting team Sydney

FAQ

TGA regulatory consulting — common questions

General information only — not legal or regulatory advice.

What does a TGA regulatory consultant do?

A TGA regulatory consultant guides pharmaceutical and medical device companies through the process of registering products on the Australian Register of Therapeutic Goods (ARTG). This includes advising on the right registration pathway, preparing and lodging dossiers with the TGA, acting as or supporting the Australian sponsor, responding to TGA evaluation questions, and ensuring ongoing post-market compliance.

Does an overseas company need an Australian sponsor?

Yes. Products supplied in Australia must be included on the ARTG by an Australian sponsor — an Australian resident or company that takes legal responsibility for the product. Overseas companies typically appoint a regulatory consultant or service provider to act as sponsor, or establish an Australian entity for the purpose.

What is the ARTG?

The Australian Register of Therapeutic Goods (ARTG) is the database maintained by the TGA of therapeutic goods — medicines, medical devices, biologicals and IVDs — that are approved for supply in Australia. A product must be included on the ARTG before it can be legally supplied in Australia.

Can existing FDA or EMA approvals speed up TGA registration?

In many cases, yes. The TGA accepts overseas regulatory decisions from comparable regulators (FDA, EMA, Health Canada, UK MHRA) as part of its evidence framework. This can shorten evaluation timelines and reduce the volume of data required, particularly for prescription medicines and medical devices.

Can you support both TGA and FDA programmes simultaneously?

Yes — managing both FDA and TGA pathways from one team is central to what we do. We coordinate US and Australian regulatory work so your submissions move forward in step and development data supports both filings where possible.

Where are your TGA consultants based?

Our TGA regulatory consultants are based in Sydney, NSW, Australia. We also have US presence, which allows us to support dual-market programmes across both FDA and TGA without coordinating between separate firms.

Start here

Talk to a TGA regulatory consultant today

Whether you are registering your first product on the ARTG, need an Australian sponsor, or are preparing for a TGA GMP inspection — book a free consultation and we will outline the right path forward.

Sydney, NSW, Australia · enquiries@tpccompliances.com